chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle ache after a week later which just lasted for a day), MYALGIA (muscle aches 2 days later (10 days ago)) and MYALGIA (back muscle aches 2 days later (10 days ago)) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced MYALGIA (muscle ache after a week later which just lasted for a day). On 09-Mar-2021, the patient experienced MYALGIA (muscle aches 2 days later (10 days ago)) and MYALGIA (back muscle aches 2 days later (10 days ago)). On 15-Feb-2021, MYALGIA (muscle ache after a week later which just lasted for a day) outcome was unknown. At the time of the report, MYALGIA (muscle aches 2 days later (10 days ago)) and MYALGIA (back muscle aches 2 days later (10 days ago)) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. concomitant medication was not provided. Patient was taking Tylenol and Advil occasionally to treat symptoms. This case was linked to US-MODERNATX, INC.-MOD-2021-051440 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-051440:Crosslinked with dose 2.
1 week after receiving the vaccination, a red welt appeared on my arm where the injection was given. It was hot, raised and itchy and about an inch and a half wide and long. I drew a line around it. The next day it was less itchy and hot but had gone about half an inch outside the initial lines. The third/ fourth day it was barely raised at all but had gotten even larger, now about 1.5-2inches outside the initial lines in some areas. It is now barely raised, barely red and has not gotten any larger since yesterday.
On day 8, my arm had a red, swollen and itchy circle about the size of a mini football.  It started to fade a few days later, but traveled a bit down the arm.  It is now day 12, and it is still there a bit but faded
herpes zoster; post herpetic neuralgia; Bell's palsy; tremors; Information has been received from a lawyer referring to a patient of unknown age and gender. Information about concurrent condition, history condition and concomitant medication was not reported. On or about 12-AUG-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date unknown) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). After receiving zoster vaccine live (ZOSTAVAX), the patient suffered from herpes zoster, post herpetic neuralgia, Bell's palsy and tremors. As a result of these symptoms, the patient was seen and treated by medical providers. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the vaccine. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of the condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events herpes zoster, post herpetic neuralgia, Bell's palsy and tremors was considered to be not recovered and causal relationship was assessed as related.    The lawyer considered the events herpes zoster, post herpetic neuralgia, Bell's palsy and tremors to be disability.   Upon internal review, Bell's palsy was determined to be medically significant.
The day following immunization, patient's lymph nodes became swollen especially notable in the underarm area bilaterally, indicating a systemic autoimmune reaction to the vaccine. Symptoms lasted for 10 days. On the evening of 1/7/2017 patient went to the ER for severe chest pain and heart palpitations. Pain was determined to be caused by Eosinophilic Esophagitis (dx via EG biopsy), related to NEW egg allergy (patch test confirmed). Egg albumin is an ingredient in the FLUARIX vaccine. Injecting food proteins is known to cause food sensitivities and allergies. Upon receiving positive allergy test results for egg allergy Pt eliminated eggs, chicken and turkey from diet and incorporated non-prescription practices. Follow-up Endoscopy in August 2017 showed that her efforts had cured the Eosinophilic Esophagitis, but had left scarring caused by the disease.
Recd via e-mail: Subject has a latex allergy and received the anthrax vaccine. Subject is requesting information regarding whether the vaccine is made/stored in nitrile.
Patient received Hep B vaccine for employee health and developed severe itching and hives on torso region and upper extremities.
On an unspecified date, the pt received injections of Engerix-B and Havrix for "revaccination". The number of previous injections of Engerix-B and Havrix were not specified. On 9/28/01, the pt was seen in the physician's office and in the ER. He was hospitalized with a dx of second nerve bilateral optic papillitis. As of 10/3/01, the event was ongoing. F/U states the vaccine provider submitted this report directly to VAERS. The pt received Hep-A on 12/14/98 and 6/14/99. On 8/31/01, the pt received injections of Havrix and Engerix-B. On 9/28/01, the pt received his 2nd injection of Engerix-B. As he drove home from the MD's office, he noticed greyness of vision at the inferior field of the left eye when he covered his right eye. On 10/2/01, he was seen by an ophthalmologist, who made a dx of bilateral papillitis, left greater than right. The pt was sent to the ER for further evaluation and was hospitalized. On admission, the pt reported that he had noted transient dizziness, lightheadedness and blurry vision while exercising 1 week prior to admission; these events resolved after several minutes. He also reported "some ill-defined mild decrease in concentration skills and general fatigue up recently. The dizziness, lightheadedness, blurry vision, decreased concentration and fatigue were not reported by the MD as symptoms of papillitis; the physician recorded the onset of papillitis as 9/28/01 PM. The pt recorded that he had no fever, focal weakness, dysesthesias, urine or stool incontinence, headache, stiff neck, dysphagia, nausea, vomiting or seizure-like activity. The pt was treated with acyclovir, ceftriaxone and acetylsalicylic acid 325mg daily. He received levofloxacin (Levaquin) 500mg daily for an unspecified number of days; it was discontinued 4 days after discharge from the hospital when Bartonella henselea serologies were reported as negative. He also received 1 injection of benzathine penicillin 2.4 million units; this was "not re-administered given the negative peripheral syphilis serologies". During the hospitalization, the visual acuity in the left eye decreased from 20/20 to 20/60. "He had no fevers, no headaches and no other visual changes during his stay". The pt was discharged to home in stable condition on 10/6/01. Discharge dx was "Bilateral papillitis, left greater that right". In the submission to VAERS, the vaccine provider reported the dx as "Bilateral optic neuritis thought to be vaccine associated". The most recent information was received on 10/22/01. The physician reported that the pt was seen as an outpt on 10/12/01. At that time, the pt "noted some very minor improvement in visual acuity". The physician stated, "no further specific treatment or testing was warranted at that time". The pt remained under the care of an ophthalmologist and the PCP. There were no known adverse experiences following receipt of prior immunizations and no known illnesses at the time of immunizations.
It has a side effects i got sick; Yes i gave me a bad effect on me; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (It has a side effects i got sick) and FEELING ABNORMAL (Yes i gave me a bad effect on me) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (It has a side effects i got sick) and FEELING ABNORMAL (Yes i gave me a bad effect on me). At the time of the report, ILLNESS (It has a side effects i got sick) and FEELING ABNORMAL (Yes i gave me a bad effect on me) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment details was not provided
Based on the information received on 25-Oct-2018, the narrative of the case was amended in the analysis tab. Initial information received on 26-Sep-2018 regarding an unsolicited valid non-serious case received from a consumer. This case is linked to case 2018SA272314. (Same reporter). This case involves an 87 years old male patient who experienced pain in right arm, while he received vaccine INFLUENZA VACCINE. The patient's past medical history included Arthralgia, Blood calcium abnormal, Bone density abnormal with bone density issues in that arm and now that pain from the arthritic shoulder, and H2N2 influenza (Flu) with fever of 102 F in 1950's. The patient's past vaccination(s) included INFLUENZA VACCINE with "heavy dose" and they had arm pain. The patient's past medical treatment(s) and family history were not provided. Concomitant medication was none. Reported as No concomitant vaccines given. On an unknown date (reported as last week), the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in the right arm. On an unknown date, the patient developed a non-serious pain in right arm (pain in extremity) following the administration of INFLUENZA VACCINE. It was also reported that now that pain from the arthritic shoulder is "over ceded/overshadowed" from the pain from the vaccine. (Other relevant tests included No lab data.) Final diagnosis was pain in right arm. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for pain in right arm. List of documents held by sender: none.
This spontaneous report as received from a Licensed Vocational nurse (LVN) and refers to unspecified patients of unknown age and gender. Medical history and concurrent conditions were not reported. Since July 2015, the patient was vaccinated with improperly stored GARDASIL injection (lot number: K006960 and expiry date: 19-FEB-2017) (dose, frequency, route and indication not reported) (incorrect product storage). No concomitant medications were reported. No adverse effects were reported. The outcome of incorrect product storage was unknown. No product quality complaint (PQC) was filed. No further information provided. Additional information has been requested.
Dose 1- 03Feb2021 and Dose 2- 19Mar2021; Sore arm at injection site; Swollen lymph node left armpit; sore underarm; This is a spontaneous report  from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via unspecified route of administration in the left arm on 19Mar2021 at 12:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic back pain (chronic lower back pain) and latex allergy. Concomitant medications included oxycodone and acetaminophen (MANUFACTURER UNKNOWN) and etonogestrel; ethinyl estradiol (NUVARING) from unknown date for unspecified indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via unspecified route of administration in the left arm on 03Feb2021 at 16:00 (at the age of 40-years-old)  as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 20Mar2021 at 21:00, patient experienced sore left arm at injection site, swollen lymph node at left armpit, and and sore underarm .The patient received first dose on 03Feb2021 and second dose on 19Mar2021 (Inappropriate schedule of vaccine administration). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome for sore left arm at injection site, swollen lymph node at left armpit, and and sore underarm and inappropriate schedule of vaccine administration was unknown.   No follow-up attempts are needed. No further information is expected.
I can't get up; I cannot walk; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 2021, outcome "unknown", described as "I can't get up"; GAIT DISTURBANCE (non-serious) with onset 2021, outcome "unknown", described as "I cannot walk".  Additional information: Consumer stated, "What I am seeing is, because I see the 'doctor' wrote on my is, this is on the top is 08Sep2021, that is for the second shot. "When probed of consumer got the second shot, consumer stated, "No, I got the first one." When again clarified the concern, consumer stated, "I want to know, the date is confusing for the second one. "Scheduled date for second shot: Consumer stated, "This is what is written 'I do not know, 08Sep2021 at 03:00 PM'. When clarified if the date for second shot is 08Sept2021, consumer stated, 'I was just calling for the date" When probed if consumer missed the second dose, consumer stated, "No, I wanted to make sure if it is scheduled for today. So, it is for today, right?" Consumer was advised to take the second dose on the scheduled date. Consumer further stated, "All I wanted to know if it is for today at 3 o'clock, that's all I wanted to know. I do not know that is why I want to know if I have to call, I can't get up." Consumer was provided with the number of Pfizer Medical Information and also advised to contact vaccination Center for vaccination date and timing. Consumer further stated, "Yes, I am going to the hospital, yes." In response to further probing, consumer stated, "I cannot walk, I am (voice not clear), I am trying to know, if I find out, if it could be, (voice not clear) so I am trying to look about at."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
TESTED POSITIVE FOR COVID; This spontaneous report received from a pharmacist concerned a 45 year old male. The patient's weight was 100 kilograms, and height was 71 inches. The patient's concurrent conditions included: fatty liver, dyslipidemia, diabetes, and hypertension. Patient reported no allergy to medication, food and other products. It was unknown if patient had any acute illness at the time of vaccination and up to one month before vaccination. Patient did not experience any similar event in the past. The patient received covid-19 vaccine ad26.cov2.s (dose number in series: 1) (suspension for injection, intramuscular, batch number: 1808980, and expiry: UNKNOWN) 0.5 ml, 1 in total administered to arm on 09-APR-2021 for prophylactic vaccination. On 22-DEC-2021, the patient tested positive for covid, the type of test was unknown. (dose number in series: 1). Laboratory data included: COVID-19 virus test (NR: not provided) Positive.  On 24-JAN-2022, at 08:50 AM the patient received Non-company suspect vaccine included: mrna 1273 (dose number in series: 2) (intramuscular, batch number: 070H21A expiry: UNKNOWN, form of admin was not reported) 0.25 ml, vaccinated to arm for prophylactic vaccination.  No adverse events were reported following mrna 1273 (dose number in series: 2). Concomitant medications included insulin aspart for diabetes, insulin glargine for diabetes, metformin for diabetes, atorvastatin for dyslipidemia, and candesartan for hypertension.  The patient recovered from expired vaccine administered on 24-JAN-2022. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was non-serious.
COVID Breakthrough. Patient tested positive on 2/22/22 while hospitalized for other reasons. Mostly asymptomatic for COVID.
No adverse event; administered a 2nd dose of the Vaccine on 14MAR2023 but they realized the vaccine was expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered a 2nd dose of the Vaccine on 14MAR2023 but they realized the vaccine was expired) and NO ADVERSE EVENT (No adverse event) in a 33-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 071B22A) for COVID-19 prophylaxis.     Previously administered products included for Product used for unknown indication: flu vaccine. Past adverse reactions to the above products included No adverse event with flu vaccine.    On 14-Mar-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 14-Mar-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (administered a 2nd dose of the Vaccine on 14MAR2023 but they realized the vaccine was expired). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered a 2nd dose of the Vaccine on 14MAR2023 but they realized the vaccine was expired) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered a 2nd dose of the Vaccine on 14MAR2023 but they realized the vaccine was expired).    No concomitant medication were reported. It was stated that no AEs were reported. No treatment information was provided by the reporter.
The vaccine was diluted with 1.8ml of the diluent. There was a misunderstanding and the pharmacist thought the same amount was also drawn up to be injected to the patient. The patient got too much of the dose.
husband just had the Covid booster and within 8 hours having hematuria; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete , unknown manufacturer), for COVID-19 Immunization. The following information was reported: HAEMATURIA (non-serious), outcome "unknown", described as "husband just had the Covid booster and within 8 hours having hematuria". Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: The patient just had the COVID booster and within 8 hours having hematuria. All his labs, urinalysis and a CT were clear, but the reporter had read that this was a very rare potential side effect.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Rash developed 8 days after second covid vaccine. On my neck, jawline, cheeks, ears, forehead, and around my eyes. Rash is red, blotchy, itchy. So far has persisted for 3 days with no improvement. NiceTreating with methylprednisolone dosepack, oral antihistamines, topical steroids, and topical diphenhydramine. No improvement.
This spontaneous case reported by a physician, describes the occurrence of administered expired product (administration of expired vaccine) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 006C21A) for COVID-19 immunization. No medical history reported. On Jun 15, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jun 15, 2021, patient administered expired product (administration of expired vaccine). On Jun 15, 2021, administered expired product (administration of expired vaccine) resolved. The reporter did not provide any causality assessments, concomitant medication information and treatment information.
Left deltoid swollen and erythematous and itchy (2 days after immunizations). Tx with cold packs and Zyrtec.